ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Tilray Brands Inc

Tilray Brands Inc (TLRY)

0.8737
-0.0209
(-2.34%)
마감 20 2월 6:00AM
0.8775
0.0038
(0.43%)
시간외 거래: 9:59AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
0.8702
매수가
0.8702
매도가
0.8775
거래량
56,610,970
0.8455 일간 변동폭 0.8946
0.87 52주 범위 2.97
market_cap
전일 종가
0.8946
개장가
0.89
최근 거래 시간
120
@
0.8702
(formt)
마지막 거래 시간
재정 규모
US$ 48,965,347
VWAP
0.864945
평균 볼륨(3m)
42,165,626
발행 주식
937,655,195
배당수익률
-
주가수익률
-3.33
주당순이익(EPS)
-0.26
매출
804.73M
순이익
-244.98M

Tilray Brands Inc 정보

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists ... Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater. 더 보기

섹터
Medicinal Chems,botanicl Pds
산업
Medicinal Chems,botanicl Pds
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Tilray Brands Inc is listed in the Medicinal Chems,botanicl Pds sector of the 나스닥 with ticker TLRY. The last closing price for Tilray Brands was US$0.89. Over the last year, Tilray Brands shares have traded in a share price range of US$ 0.87 to US$ 2.97.

Tilray Brands currently has 937,655,195 shares in issue. The market capitalisation of Tilray Brands is US$838.83 million. Tilray Brands has a price to earnings ratio (PE ratio) of -3.33.

Tilray Brands (TLRY) 옵션 플로우 요약

전체 흐름

강세

순 프리미엄

30k

Calls / Puts

100.00%

매수 / 매도

100.00%

OTM / ITM

100.00%

Sweeps 비율

0.00%

TLRY 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.0568-6.127292340880.9270.97430.87373357880.9254501CS
4-0.2898-24.98275862071.161.20.87489705411.02404599CS
12-0.4998-36.48175182481.371.530.87421656261.1952852CS
26-1.0698-55.14432989691.941.960.87321434641.38720952CS
52-1.0398-54.43979057591.912.970.87292773581.67106764CS
156-5.3298-85.9645161296.29.080.87249962352.82954184CS
260-16.2298-94.911111111117.166.980.87230025077.24904874CS

TLRY - Frequently Asked Questions (FAQ)

What is the current Tilray Brands share price?
The current share price of Tilray Brands is US$ 0.8702
How many Tilray Brands shares are in issue?
Tilray Brands has 937,655,195 shares in issue
What is the market cap of Tilray Brands?
The market capitalisation of Tilray Brands is USD 838.83M
What is the 1 year trading range for Tilray Brands share price?
Tilray Brands has traded in the range of US$ 0.87 to US$ 2.97 during the past year
What is the PE ratio of Tilray Brands?
The price to earnings ratio of Tilray Brands is -3.33
What is the cash to sales ratio of Tilray Brands?
The cash to sales ratio of Tilray Brands is 1.01
What is the reporting currency for Tilray Brands?
Tilray Brands reports financial results in USD
What is the latest annual turnover for Tilray Brands?
The latest annual turnover of Tilray Brands is USD 804.73M
What is the latest annual profit for Tilray Brands?
The latest annual profit of Tilray Brands is USD -244.98M
What is the registered address of Tilray Brands?
The registered address for Tilray Brands is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Tilray Brands website address?
The website address for Tilray Brands is www.tilray.com
Which industry sector does Tilray Brands operate in?
Tilray Brands operates in the MEDICINAL CHEMS,BOTANICL PDS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
JTAIJet AI Inc
US$ 10.1006
(148.78%)
149.38M
EDITEditas Medicine Inc
US$ 3.19
(83.33%)
49.89M
SINTSiNtx Technologies Inc
US$ 4.79
(69.86%)
70.97M
LYTLytus Technologies Holdings PTV Ltd
US$ 0.363
(63.07%)
215.48M
AGHAureus Greenway Holdings Inc
US$ 3.8501
(42.07%)
1.02M
CNSPCNS Pharmaceuticals Inc
US$ 0.0838
(-41.19%)
88.17M
HCTIHealthcare Triangle Inc
US$ 0.4409
(-38.76%)
3.19M
NKLANikola Corporation
US$ 0.4711
(-38.49%)
110.5M
BPTHBio Path Holdings Inc
US$ 0.1322
(-37.05%)
2.14M
GLSTUGlobal Star Acquisition Inc
US$ 7.26
(-36.04%)
4.41k
ADTXAditxt Inc
US$ 0.1288
(17.09%)
612.1M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0616
(13.03%)
482.51M
SMCISuper Micro Computer Inc
US$ 60.25
(7.97%)
338.03M
LYTLytus Technologies Holdings PTV Ltd
US$ 0.363
(63.07%)
215.48M
NVDANVIDIA Corporation
US$ 139.23
(-0.12%)
168.02M

TLRY Discussion

게시물 보기
tapioca tapioca 7 시간 전
Ok, I thought it was 30 days. That’s better then
👍️ 1
nssrr5 nssrr5 8 시간 전
No you have to be under a buck for a year. SO we are only 12 days in and at that point they discuss the review which take another 6 months but I do totally get your concern.
👍️0
tapioca tapioca 8 시간 전
I don’t know when they’re up for review, but I would think there is one this year? But if you say not til next year that would be good.
👍️0
nssrr5 nssrr5 8 시간 전
That is where we differ as the Nasdaq compliance is a non-issue. It would take well over a year to even become an issue with the Nasdaq and this has only been under a buck since 2/7/25. A very short time. IF we are under a buck mid-2026 then I would start to worry.
👍️0
tapioca tapioca 10 시간 전
Yea this slow bleed down and new 52wk lows being put in daily is just crazy. I'll definitely be jumping in at some point, but now have to worry about Nasdaq compliance which I mentioned a while ago as it is well below a a buck now.
👍️0
BottomBounce BottomBounce 11 시간 전
https://seekingalpha.com/article/4758892-tilray-cannabis-stock-improved-balance-sheet-reasonable-valuation-rating-upgrade $TLRY
👍️0
BottomBounce BottomBounce 11 시간 전
Tilray Brands Has Diversified Its Business Through Alcohol, but Is the Stock a Better Buy Than It Was 5 Years Ago? https://finance.yahoo.com/news/tilray-brands-diversified-business-alcohol-104500145.html $TLRY

👍️0
nssrr5 nssrr5 12 시간 전
If I was you I would keep waiting - this is for sure going below .80
👍️0
tapioca tapioca 1 일 전
Not much dry powder on hand so I almost sold TRUG, to get in here but held off. TRUG releases news AHs, and it’s up 50%. Christ what a game we play..
👍️ 1
nssrr5 nssrr5 1 일 전
Well your gut feeling has been correct so far.
👍️0
tapioca tapioca 1 일 전
Not much bid support, such weird trading with high volume .. it still looks like shorts are just destroying it. It should be a meme stock… sheeesh. This fractional trading, ugh.
Everytime I think about jumping in, I don’t ..lol.
👍️0
nssrr5 nssrr5 1 일 전
I feel it's just pure manipulation at this point...
👍️0
tapioca tapioca 1 일 전
You have to ask yourself who or what is selling at these levels… seems crazy
👍️0
nssrr5 nssrr5 2 일 전
Praying this is the case but I will believe it when I see it. Maybe Baby Bear Eating RFK JR is crazy enough to get it done
👍️0
BottomBounce BottomBounce 2 일 전
Trump Ally Who Lobbies For Marijuana Industry Predicts Rescheduling And Banking Will Get Done Under New Administration https://marijuanamoment.net/trump-ally-who-lobbies-for-marijuana-industry-predicts-rescheduling-and-banking-will-get-done-under-new-administration-but-not-legalization/ $TLRY $MJ $MSOS $TOKE
👍️0
nssrr5 nssrr5 3 일 전
I made a Killing in SNDL years ago when people were screaming they needed to do something to stay compliant as I kept gobbling up shares in the .40 and .50 range and then it ran over 4 bucks a share.

I will do the same here but this time when it runs there will be no retreat. When this rockets from these levels it will be because it will finally be Cannabis time. Decriminalization is coming at some point and Tilray has set itself up to be the most dominant Cannabis Company in the World IMHO. This is like buying a .com before the internet boom....

I could be wrong about everything I type but I 1000% believe it, regardless of what the DoomLoooooser's of the world have to say about it. Not talking about you my friend but the other poster I have on IGNORE LOL.

Good Luck to you Tapioca - anything down here is an absolute gift long term of course... Again all in my humble opinion.
👍 1
BottomBounce BottomBounce 4 일 전
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada. $TLRY
👍 1
tapioca tapioca 5 일 전
Still looking for an entry. But I’m sure the company is going to have to bring this back above a buck, and stay there, to continue to be compliant with Nasdaq. There seems to be plenty of buying but is it the shorts holding it down? The volume is quite high.
👍 1
nssrr5 nssrr5 6 일 전
She was creeping up this morning pre-market but has seemed to settle back down. .90 held yesterday but who knows where this will bottom. I hope it was yesterday but time will tell. Good Luck Tapioca
👍️0
doomed doomed 6 일 전

Hawaii House Shelves Recreational Cannabis Bill in Stunning Reversal

Ben Stevens (Doomed)
FEBRUARY 13, 2025
Hawaii House Shelves Recreational Cannabis Bill in Stunning Reversal

Less than 48 hours after Hawaii lawmakers appeared poised to legalize recreational cannabis, the state’s House of Representatives unexpectedly slammed the brakes, shelving the measure until at least 2032.

The sudden procedural move on Thursday, led by Representative Chris Todd, stunned advocates and lawmakers alike, reigniting frustration over the state’s stalled cannabis reform efforts.

Last week, Business of Cannabis reported that House Bill 1246 (HB 1246), championed by Representative David Tarnas, cleared two key committees: the House Judiciary and Hawaiian Affairs Committee, chaired by Tarnas, and the House Agriculture and Food Systems Committee.

The bill proposed legalizing personal cannabis use for adults 21 and over starting in 2026 while also establishing a comprehensive regulatory framework under the Department of Commerce and Consumer Affairs.

It would also have seen the creation of a new state agency, the Hawaii Cannabis and Hemp Office, to oversee both medical and recreational cannabis, as well as hemp products. It would also impose a tax on cannabis sales, as seen throughout the US.

Despite gaining momentum earlier in the week, clearing two key committees with a 6-4 and 5-0 vote, respectively, Todd introduced a rare motion to recommit the bill to committee, effectively tabling it for the year. The motion passed via voice vote without public debate.

“On this particular bill, it became clear that we did not have enough support to pass the measure in this session,” Todd told Civil Beat following the vote.

The bill remains alive for the 2026 legislative session without needing to be reintroduced, and a separate Senate proposal, SB 1613, is still under consideration.
👍️0
doomed doomed 6 일 전
Good luck guys. You are in good hands with Grumpy Trumpy!

Business of Cannabis North America
Republican Senators Introduce Bill to Block Cannabis 280E Tax Relief Even if Cannabis Is Rescheduled

Ben Stevens (doomed)
FEBRUARY 13, 2025
As the cannabis rescheduling project hangs in the balance, two Republican senators are attempting to ensure that one of its core benefits would be made redundant, even if rescheduling is successful.

Aside from the potential of interstate trade and the official acknowledgement of cannabis’ medical uses, businesses across the US are primarily looking ahead to the tax benefits that will come with rescheduling.

Section 280E of the federal tax code currently prohibits businesses involved in trafficking Schedule I or II controlled substances from deducting ordinary business expenses, leading to significantly higher effective tax rates for cannabis businesses compared to other industries.

Figures from Whitney Economics suggest that the additional tax paid by US cannabis operators due to 280E is now over $2bn a year, including hundreds of millions of dollars for some of the largest companies.

However, a newly proposed bill from senators James Lankford and Pete Ricketts would indefinitely extend this tax burden.

Under the proposed legislation, any company involved in ‘trafficking marijuana’ would remain subject to 280E, unless cannabis is completely descheduled—a scenario that remains politically improbable in the near future.

Lankford, a long-time cannabis opponent, framed his bill as a safeguard against legitimizing the industry.

“Marijuana doesn’t make our families stronger, our streets safer, or our workplaces more productive,” he stated, adding.

The effort has been strongly backed by Smart Approaches to Marijuana (SAM), a prohibitionist advocacy group which has already proven a major hindrance to the rescheduling process.

SAM President Kevin Sabet hailed the bill as a way to prevent what he called $2.3 billion in ‘tax cuts’ for the cannabis industry, stating that ‘the federal government should not be in the business of giving tax relief to the federally addiction-for-profit marijuana industry.’

The bill has sparked sharp criticism from cannabis industry advocates, who argue that maintaining 280E restrictions will only benefit the illicit market by making legal cannabis less competitive.
👍️0
doomed doomed 6 일 전
Business of Cannabis North America
Trump’s DEA Revolving Door: 4th Administrator in as Many Months Rings Alarm Bells for Cannabis Industry
FEBRUARY 13, 2025
The fourth head of the Drug Enforcement Administration (DEA) in as many months has been given the green light by President Donald Trump, painting an even more worrying picture for the future of cannabis in the US.

Trump has now nominated anti-cannabis Terrance C. Cole as the next DEA administrator, less than a month after appointing long-time cannabis sceptic Derek S. Maltz as ‘acting administrator.’

While it’s not yet clear why Maltz was shunned so quickly, his replacement, a 30-year law enforcement veteran and former DEA official, has caused even more panic in the country’s cannabis community.

Cole has historically taken an even more hardline stance than his all-too-temporary predecessor, publishing numerous public posts claiming, among other things, that cannabis is ‘four times more dangerous’ than 30 years ago, that it leads to higher suicide risk, while advocating a #justsayno stance.

Before taking office, Cole must still be confirmed by the Senate, which could prove to be a contentious process given his hardline stance on cannabis and drug enforcement. If confirmed, he will inherit the rescheduling review, along with growing scrutiny over the DEA’s role in delaying administrative hearings on the proposal.

While this places the rescheduling process on even more dangerous territory, one analyst told Business of Cannabis that it could signal much more serious consequences for cannabis policy in the country.

Deborah Tharp, cannabis legal researcher and consultant, says that this gives legitimacy to the theory that the administration is attempting to push through Project 2025 regardless of public opinion, including a war on state-legal cannabis.

“Trump has hardcore prohibitionists in all the right places now. Time to start praying for miracles.”

However, she stipulates that his choices reveal a lack of cohesive policy, no surprise given the president’s tendency to change his position on key topics on a dime.

This has already been demonstrated in his picks for the head of the DEA. Matt Gaetz, Trump’s first selection for administrator, announced in November that he was withdrawing himself from the process as he dealt with a House of Ethics Committee investigation into sexual misconduct.

His next choice, Florida County Sheriff Chad Chronister, abruptly withdrew his nomination for the post just weeks later.

Chronister’s sudden exit was initially framed as a voluntary withdrawal, citing dedication to his constituents; however, Trump soon sought to correct this to his own narrative, stating: “He didn’t pull out. I pulled him out because I did not like what he said to my pastors and other supporters.”

With suspicions that the far-right think tank, The Heritage Foundation, is largely guiding this administration, Tharp fears the US is ‘going to get very, very regressive’ in the coming months and years.
👍️0
nssrr5 nssrr5 6 일 전
I sure hope so.....
👍️0
tapioca tapioca 6 일 전
Ha, he’s into the hard stuff…what a joke.
We could very well be seeing the bottom here..
👍️0
nssrr5 nssrr5 6 일 전
Maybe our new Baby Bear Eating US Health Secretary can do something for the Cannabis Sector like some believe. Not holding my breath...
👍️0
doomed doomed 6 일 전
I understand why Floridians would buy Tilray…
They got nothing to lose!
👍️0
doomed doomed 6 일 전
Americans are on meth and the rest are on fentanyl.
There is no money left for bunk 20$ grams after buying eggs.
Maga rules until inflation hits the peak.
👍️0
doomed doomed 6 일 전
Installing DEA Terrance Cole in charge of canna legalization makes it easy for Grumpy Trumpy…
Dude cannot be trusted. Besides maga/dea don’t want no druggies.😂🤣😂
👍️0
nssrr5 nssrr5 6 일 전
It really is just a guessing game LOL. I just keep averaging down as I am playing the long game here. Got my average down to 1.74 or somewhere in there. A long way back to even...
👍️0
tapioca tapioca 6 일 전
I was going to say that some got suckered into buying in the .96 range, but was also thinking no one knows where the bottom is either, and then it dropped to .90 and hit a new 52wk low again. lol. Tough to know where to jump back in.
👍️ 1
doomed doomed 7 일 전
Good call! It will rocket back.
👍️0
drumkids drumkids 7 일 전
Trending
👍️0
nssrr5 nssrr5 1 주 전
Went on and added - none of is know where the bottom is so I added here. We could get .80 or .70 but this could also rocket back over a dollar.... So over sold IMHO - good luck all.
👍️0
doomed doomed 1 주 전
Sales pitch for canna naive investers!
Purchase shares before price go down…🤣😂🤣
👍️0
doomed doomed 1 주 전
Forbes wants cannabis naive investors to purchase mores cannabis shares. 🤣😂

You are in business with agent Terrance Cole.

D.E.A. Is pushing for cannabis legalization.

You guys are GOLDEN.

You will be rich.
👍️0
doomed doomed 1 주 전

Trump taps career DEA official to lead agency, oversee marijuana rescheduling
Doomed
February 12, 2025

President Donald Trump’s choice to lead the U.S. Drug Enforcement Administration is Terrance Cole, a career anti-cannabis DEA official currently serving as a top law enforcement official in Virginia.

The appointment of a longtime DEA insider – which Trump announced midday Tuesday in a social media post – is not likely to boost hopes that the agency will resume the Biden administration-initiated marijuana rescheduling process.

A previous Trump pick to head the DEA, Chad Chronister, a Florida sheriff, abruptly withdrew his nomination for the post.

Cole served more than two decades in the DEA, retiring in 2020 as the acting regional director overseeing operations in Canada, Central America and Mexico.

Trump has said he supports marijuana rescheduling, but Cole’s resume does not suggest he may embrace cannabis reform.

Cole worked under Virginia’s anti-marijuana governor
after exiting the DEA, Cole joined Virginia Gov. Glenn Youngkin’s administration, where he served as the state secretary of public safety and homeland security.

Youngkin, who has repeatedly opposed adult-use marijuana sales in Virginia, praised Cole’s appointment.

“He will put the safety and security of Americans first as head of the DEA,” Youngkin said in a statement.

“It’s a great day to be an American and a bad day to be a drug dealer.”

If confirmed by the Senate, Cole would assume control of the paused marijuana rescheduling process.

Marijuana rescheduling process remains up in air.

Rescheduling has been on hold since January after pro-legalization “designated participants” in hearings before a DEA administrative law judge accused the DEA of bias.

Critics have accused the DEA of slow-walking the process and refusing to hear evidence from states, including Colorado, in support of the change.

Considering those designated participants’ appeal and resuming the process – or abandoning it – is solely up to the discretion of the DEA administrator.

The acting administrator, Derek Maltz, also a longtime DEA insider, has not moved to resume the rescheduling process.

Nor did he indicate any plans one way or the other.

Capitol Hill observers believe federal agencies such as the DEA as well as Republican lawmakers will pursue whatever marijuana policy the White House demands.

However, a Trump edict issued on Inauguration Day froze all changes to federal law pending review – and approval – by a department or agency chief appointed by the president.
👍️0
tapioca tapioca 1 주 전
With the 3 branches of government now in Republican control,, things do not look good for the cannabis sector, although ACB made a big move recently. There will be a bounce off the bottom eventually, IMO, and I’ll be watching.
👍️0
nssrr5 nssrr5 1 주 전
I feel the cannabis market thinks that Trump is full of bull hense how far they have all pulled back since he won the election. I hope the market is proved wrong by our elected king.
👍️0
BottomBounce BottomBounce 1 주 전
Trump has indicated he supports reclassifying marijuana under federal drug laws as well as bill to ease access to banking services for pot companies. https://www.forbes.com/sites/ajherrington/2024/09/09/trump-backs-federal-marijuana-rescheduling-and-cannabis-banking-bill/ $TLRY
👍️0
nssrr5 nssrr5 1 주 전
Yeah I am waiting a bit with morning myself. .80s seems like they will happen and maybe even mid 70s.
👍️0
BottomBounce BottomBounce 1 주 전
$TLRY is gaining money making millions on not just weed but alcohol. Higher Lows coming.
Total Cash (mrq) $280.06M
👍️0
BottomBounce BottomBounce 1 주 전
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada. $TLRY
👍️0
tapioca tapioca 1 주 전
So tempted to buy down at these levels, but bid support doesn’t look so great at the moment. Eventually there’ll be a bottom, but just amazing to see this pps, as it continues to set new 52 week lows
👍️0
doomed doomed 1 주 전
Bag holder😂🤣😂🎯
👍️0
nssrr5 nssrr5 1 주 전
My buying Wednesday - gobble gobble gobble. Also when will one get a clue and realize you don't looooose until you choose to sell at a loss.
👍️0
doomed doomed 1 주 전
Dude is loosing more than just losing😂🤣😂
Maga are born loser.
They love to shoot themselves in the foot.🦶
They are proud!
👍️0
nssrr5 nssrr5 1 주 전
HAHA
👍️0
tapioca tapioca 1 주 전
It’s spelled loser, with one s, not “looser”, which is how your hat is if your head shrinks
👍️0
doomed doomed 1 주 전
Nssrr5 is a professional bag holder!
Expert money looser.😂
👍️0
doomed doomed 1 주 전
Home / Finance
GOP senators’ bill would keep 280E for cannabis operators permanently intact
Doomed
February, 11 2025
SHARE

Two Republican U.S. senators have introduced a bill that would continue to ban federal tax deductions for the cannabis industry – regardless of whether marijuana is rescheduled.

According to Law360, James Lankford of Oklahoma and Pete Ricketts of Nebraska introduced the “No Deductions for Marijuana Businesses Act,” which would essentially kill any substantive tax breaks operators hoped to receive if marijuana status were downgraded from Schedule 1 to Schedule 3 of the Controlled Substance Act.

Under Internal Revenue Code Section 280E, cannabis operators are prohibited from deducting typical business expenses, such as payroll and marketing, on federal tax returns.

So, in that respect, the senators’ proposal would not change the federal government’s ongoing policy stance regarding 280E, a provision that has wiped more than $1 billion from the balance sheet of marijuana companies nationwide.

Some tax experts expressed doubts the bill would advance, given the widespread popularity of marijuana reform, Law360 reported.

In January, the U.S. Drug Enforcement Administration’s the chief administrative law judge canceled the marijuana rescheduling process indefinitely amid accusations the agency is deliberately corrupting the hearing.

In August 2023, federal health regulators under former President Joe Biden recommended rescheduling marijuana.

👍️0

최근 히스토리

Delayed Upgrade Clock